Product References
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease.
Clinical parkinsonism & related disorders
Fernández-Espejo E,Gavito AL,Suárez J,Tolosa E,Vilas D,Aldecoa I,Berenguer J,Córdoba-Fernández A,Damas-Hermoso F,Rodríguez de Fonseca F
PA5-63757 was used in Immunohistochemistry to show that this is the first description of ATP13A2-positive inclusions outside the nervous system.
Mon Sep 12 00:00:00 UTC 2022
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease.
Clinical parkinsonism & related disorders
Fernández-Espejo E,Gavito AL,Suárez J,Tolosa E,Vilas D,Aldecoa I,Berenguer J,Córdoba-Fernández A,Damas-Hermoso F,Rodríguez de Fonseca F
PA5-63757 was used in Immunohistochemistry to show that this is the first description of ATP13A2-positive inclusions outside the nervous system.
Mon Sep 12 00:00:00 UTC 2022
Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.
Antioxidants (Basel, Switzerland)
Fernández-Espejo E,Rodríguez de Fonseca F,Suárez J,Tolosa E,Vilas D,Aldecoa I,Berenguer J,Damas-Hermoso F
PA5-63757 was used in Immunohistochemistry to study the pathological role of native αSyn, 3-NT-αSyn, and 3-NT-proteins in the saliva and submandibulary glands of patients with idiopathic Parkinson''s disease.
Sat May 01 00:00:00 UTC 2021
Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.
Antioxidants (Basel, Switzerland)
Fernández-Espejo E,Rodríguez de Fonseca F,Suárez J,Tolosa E,Vilas D,Aldecoa I,Berenguer J,Damas-Hermoso F
PA5-63757 was used in Immunohistochemistry to study the pathological role of native αSyn, 3-NT-αSyn, and 3-NT-proteins in the saliva and submandibulary glands of patients with idiopathic Parkinson''s disease.
Sat May 01 00:00:00 UTC 2021